To evaluate the results in metabolic control at newly discovered type 2 diabetic mellitus (T2DM) patients regarding the lifestyle optimization only. In this short (1 year) observational study we included a number of 1855 newly discovered T2DM patients. We compared body mass index (BMI), fasting blood glucose (FBG), HbA1c, triglycerides (TG), high density level cholesterol (HDLc) all these recorded initially at the diagnosis and then 1 year later. At baseline 52.91% males and 52.41% females were recommended only lifestyle and the rest was treated with metformin, sulfonylurea or insulin. After one year the patients who remained on lifestyle only decreased with only 5%, demonstrating that lifestyle optimization remains one of the most important "therapeutic" tools in the metabolic control of T2DM patients studied.
Adipobiology 2012; 4: 103-106.
Email this article (Login required) 
